JDRF and Diabetes UK issued a joint statement to the diabetes community on UK supplies of insulin in the build-up to the UK’s trade negotiations
A once-weekly basal insulin is in development to help treat Type 2 diabetes. Researchers suggest that reducing the frequency of basal insulin injections might help
A medication to treat Type 2 diabetes has significantly reduced blood sugar and body weight in participants of a late-phase clinical trial. Eli Lilly’s Tirzepatide is in
The FDA has approved Lilly’s Lyumjev rapid-acting mealtime insulin to reduce high blood sugar after meals and keep blood glucose levels in-range. This approval offers
An innovative new vaccine for Type 1 diabetes is being developed, which reverses certain immune responses rather than activating the immune system. “We are trying
You may have heard a lot about ordering your prescriptions online during the pandemic and wondered what it is all about. Zara Syed, Chief Pharmacist
The American Diabetes Association (ADA) and the Centers for Medicare and Medicaid Services (CMS) have announced a Part D Senior Savings Model, which will limit
The European Medicines Agency’s human medicines committee (CHMP) has recommended granting a marketing authorization in the EU for Rybelsus (semaglutide) for the treatment of adults
The American Diabetes Association (ADA) announced the formal endorsement of three bills aiming to reduce the high cost of insulin and prescription drugs. The Insulin Price
Arecor and JDRF joint research, development and commercialisation agreement. Arecor Ltd has signed a Research, Development and Commercialisation agreement with JDRF, the leading global organisation
